Federal vs Private Student Loans Key Differences Borrowers Should Know in 2026 AlphaSense Highlights 10 Major Mergers and Acquisitions Shaping 2025 South Korea Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest Home Equity Loan and HELOC Rates Hit Yearly Lows as Closing Times Vary Significantly abcoffee Secures 61 Crore in PreSeries B Funding Led by Kliff Ventures Dollar Slips Oil Declines on Hormuz Deal Optimism HRI Q1 2026 Earnings Significant EPS Beat Driven by Operational Improvements DCTH Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Continued Commercial Progress Prime Medicine Inc PRME Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Development Phase PROV Q1 2026 Earnings EPS Misses Estimates by 336 as Bottom Line Disappoints CVEO Q1 2026 Earnings Solid EPS Beat Provides Modest Glimmer Amid Seasonal Headwinds FOA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Lumexa Imaging Holdings LMRI Slides 22 as Support Levels Come Into Focus Ategrity Specialty Insurance ASIC Modestly Gains Approaching Key Resistance Workiva Inc WK Declines 195 as Stock Tests Critical Support Level Energy Vault Holdings NRGV Edges Higher Amid Renewed Interest in Energy Storage Solutions Hooker Furnishings HOFT Slides 246 Approaching Key Support at 1245 NATO Defense Spending Surge Anticipated Trump Commits 5000 Troops to Poland CRBP Q1 2026 Earnings Narrower Loss Beats Estimates but No Revenue and Sharp Share Decline Raise Concerns ATS Corporation ATS Rallies 123 Key Support and Resistance Levels to Watch Quantum Corporation QMCO Q1 2026 Earnings EPS Surprise of 2157 Driven by Cost Control Stock Declines GOVX Q1 2026 Earnings NarrowerthanExpected Loss Surprises Market LIVN Q1 2026 Earnings EPS Beats Estimates by 714 as Margins Drive Surprise DVLT Q1 2026 Earnings EPS Misses Estimates Stock Declines XRAY Q1 2026 Earnings EPS Misses Expectations Amid Uncertain Revenue Visibility Harmonic HLIT Q1 2026 Earnings EPS Shatters Estimates Stock Surges GLUE Q1 2026 Earnings WiderThanExpected Loss as PreClinical Biotech Advances Pipeline